跳至主要内容
临床试验/NCT05071001
NCT05071001已完成不适用

Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence

Gustave Roussy, Cancer Campus, Grand Paris1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2021年3月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
1
主要终点
scores obtained in FactCOG as a whole and in each subscale

研究概览

简要总结

To assess the neurocognitive outcomes in patients treated with chemotherapy for a malignant bone tumor during childhood and adolescence and the factors associated with neurocognitive impairment and/or complaints

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For study OSE A and B
  • Patients treated for a bone sarcoma: Ewing or osteosarcoma
  • Age under 19 years at initial diagnosis
  • Treated in the Pediatric Oncology Department of Gustave
  • For patients diagnosed between 01.01.2001 and 31.12.2010: patients alive in complete remission at least 5 years after diagnosis
  • Treated with at least one course of HDMTX for osteosarcoma
  • Treated without HDMTX for Ewing sarcoma
  • Time interval between the end of treatment and inclusion >10 y
  • Age > 21 y at inclusion
  • Patients with informed consent signed
  • Patient under guardianship
  • Affiliated to French health insurance or beneficiary of the same or equivalent
  • For study OSE- B only:
  • Treated with at least 8 courses of HDMTX for osteosarcoma
  • Treated without HDMTX for Ewing sarcoma
  • Patients with Ewing sarcoma will have to be matched with osteosarcoma patients according to age at the time of treatment, sex, and duration of follow-up
  • School level equivalent of at least the end of primary school

排除标准

  • For study OSE A and B
  • Brain radiotherapy
  • Previous relapse except those treated by local treatment without any chemotherapy
  • Second malignancy treated with chemotherapy
  • High dose chemotherapy with stem cell support
  • Non-French speaking patients
  • Pregnant and breastfeeding women
  • For study OSE- B only:
  • - Patient deprived of his liberty by a judicial or administrative decision

研究组 & 干预措施

A

Experimental

干预措施: MRI (Procedure)

B

Experimental

干预措施: MRI (Procedure)

结局指标

主要结局

scores obtained in FactCOG as a whole and in each subscale

时间窗: 3 years

Primary analysis will be performed on all patients included in the study, including history of Ewing (treated without HDMTX) and osteosarcoma (treated with HDMTX). This population is the main analysis population of the study.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验